ArticleOncotarget2018

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Annabelle Congras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.